NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,822 | +97399.1% | 3,130 | -3.4% | 0.13% | +2.4% |
| Q2 2023 | $327 | +9.7% | 3,241 | 0.0% | 0.12% | +6.0% |
| Q1 2023 | $298 | +1.7% | 3,241 | +0.2% | 0.12% | -1.7% |
| Q4 2022 | $293 | -99.9% | 3,234 | +26.5% | 0.12% | +29.7% |
| Q1 2022 | $224,000 | 0.0% | 2,557 | 0.0% | 0.09% | +7.1% |
| Q4 2021 | $224,000 | -11.5% | 2,557 | -17.5% | 0.08% | -11.5% |
| Q3 2021 | $253,000 | -10.6% | 3,098 | 0.0% | 0.10% | -11.9% |
| Q2 2021 | $283,000 | +10.1% | 3,098 | +3.0% | 0.11% | +0.9% |
| Q1 2021 | $257,000 | -11.1% | 3,008 | -1.7% | 0.11% | -10.7% |
| Q4 2020 | $289,000 | +8.2% | 3,060 | -0.4% | 0.12% | -14.8% |
| Q3 2020 | $267,000 | -2.6% | 3,071 | -2.0% | 0.14% | -41.6% |
| Q2 2020 | $274,000 | – | 3,133 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |